Dr. Adrian Antonio Santamaria, MD

Dr. Santamaria practices at Northwest Houston Neurology, PA in Tomball, Texas.

Dr. Santamaria's NPI, 1346444932, was assigned on June 14, 2007. Dr. Santamaria graduated from McGovern Medical School in 2003. Dr. Santamaria's Texas license number on file is N0433.

Dr. Santamaria's primary practice is Northwest Houston Neurology, PA, at 455 School St, Tomball, TX 77375 in Harris County. The practice phone is (281) 357-5678.

Dr. Santamaria's primary practice is Northwest Houston Neurology, PA in Tomball, Texas. Dr. Santamaria is also affiliated with HCA Houston Healthcare Tomball. The medical group on file is Northwest Houston Neurology. Dmand AI also links Dr. Santamaria to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Santamaria practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Santamaria's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Santamaria is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Santamaria's licenses on file in 2 states: Texas and Ohio.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, encephalopathy, epilepsy, essential tremor, fibromyalgia and chronic pain, hypersomnia and lower back pain among the conditions Dr. Santamaria treats.

CMS data shows 2,214 Medicare services from Dr. Santamaria across 17 procedure codes in 2024, for 609 Medicare patients. Medicare paid $328,655 for them.

CMS counts 609 Medicare patients who saw Dr. Santamaria in 2024. The largest group is 65 to 74, with 262 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Santamaria's median patient age at 62, with 51% women.

In 2024, Dr. Santamaria wrote 3,061 Medicare Part D claims for 490 patients. 86% of them were for generic drugs. CMS names the drug for 2,701 of them, across 61 drugs with 11 or more claims each, at $2,644,618 in total drug cost. In 2023, CMS named 2,346 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Santamaria for performance year 2024, reported individually. Dr. Santamaria accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Santamaria as offering telehealth.

Dmand AI links 2 papers to Dr. Santamaria in 2024. Dr. Santamaria's most frequent co-authors are Brian Keith Abaluck, MD, Akinyemi Olutoye Ajayi, MD and Bruce Clayton Corser, MD.

Dmand AI links Dr. Santamaria to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Cataplexy, Idiopathic Hypersomnia and Narcolepsy.

CMS Open Payments shows 712 general payments to Dr. Santamaria from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Jazz Pharmaceuticals Inc. paid the most, $114,254.

Dmand AI lists 1 award for Dr. Santamaria, most recently CMS Stage 1 EHR in 2013.

Dr. Santamaria graduated from McGovern Medical School in 2003. Dr. Santamaria is a member of AAN and AASM.

Dr. Santamaria is in network with 21 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.